FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

G & W Clobetasol Propionate Ointment 0 Recall

G & W Clobetasol Propionate Ointment 0

G & W Laboratories, Inc. · South Plainfield, NJ

Risk level
Class III
Reported by FDA
Jul 12, 2017
Recall ID
D-0945-2017
Check your lot numberHow we source this data

Summary

G & W Laboratories recalled G & W Clobetasol Propionate Ointment 0 starting Jun 2, 2017. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0945-2017 on Jul 12, 2017. Reason: Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product. Status: Terminated.

Why it was recalled

Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.

Product description

G & W Clobetasol Propionate Ointment 0.05%, packaged in a) 15 g tube (NDC 0713-0656-15), b) 30 g tube (NDC 0713-0656-31, c) 45 g tube (NDC 0713-0656-37), d) 60 g tube (NDC 0713-0656-60), Rx Only, Manufactured by G & W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080

Lot numbers, UPCs & expiration codes

Lot #: a) 1001090, Exp 8/ 17; 1002881, Exp 2/18; b) 1001086, Exp 8/ 17; 1001154, Exp 11/ 17; 1001156, Exp 9/17; 1002882, Exp 2/18, 1004564, Exp 7/18; c) 1001155, Exp 9/17; 1004572, Exp 7/18; d) 1001158, Exp 9/17; 1001159, Exp 10/17; 1002884, Exp 4/18

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0945-2017
Classification
Class III
Status
Terminated
Recall initiated
Jun 2, 2017
FDA report date
Jul 12, 2017
Quantity
145284 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
G & W Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0945-2017, exactly as published.

Show all FDA fields
City
South Plainfield
State
NJ
Status
Terminated
Country
United States
Event ID
77401
Address
111 Coolidge St
Code information
Lot #: a) 1001090, Exp 8/ 17; 1002881, Exp 2/18; b) 1001086, Exp 8/ 17; 1001154, Exp 11/ 17; 1001156, Exp 9/17; 1002882, Exp 2/18, 1004564, Exp 7/18; c) 1001155, Exp 9/17; 1004572, Exp 7/18; d) 1001158, Exp 9/17; 1001159, Exp 10/17; 1002884, Exp 4/18
Postal code
07080-3895
Report date
Jul 12, 2017
Product type
Drugs
Recall number
D-0945-2017
Classification
Class III
Recalling firm
G & W Laboratories, Inc.
Product quantity
145284 tubes
Termination date
May 9, 2018
Reason for recall
Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
G & W Clobetasol Propionate Ointment 0.05%, packaged in a) 15 g tube (NDC 0713-0656-15), b) 30 g tube (NDC 0713-0656-31, c) 45 g tube (NDC 0713-0656-37), d) 60 g tube (NDC 0713-0656-60), Rx Only, Manufactured by G & W Laboratories, Inc. 111 Coolidge Street, South Plainfield, NJ 07080
Distribution pattern
Nationwide
Recall initiation date
Jun 2, 2017
Initial firm notification
Letter
Center classification date
Jul 6, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0945-2017, published Jul 12, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls